analyz
characterist
seven
monoclon
antibodi
mab
rais
purifi
hemagglutininesteras
glycoprotein
murin
coronaviru
dvim
diarrhea
viru
infant
mice
immunocrossreact
mab
jhm
andor
mhv
suggest
antigen
epitop
dvim
similar
jhm
andor
mhv
four
mab
design
group
mab
strongli
inhibit
ha
ae
activ
hand
three
mab
refer
group
b
compar
weak
ha
inhibit
activ
result
indic
antigen
epitop
glycoprotein
classifi
least
two
group
function
site
ha
ae
activ
similar
ident
neutral
activ
shown
group
mab
exclus
suggest
ratio
ha
andor
ae
activ
may
play
import
role
cell
fusion
activ
dviminfect
cell
coronavirus
envelop
virus
contain
singlestrand
rna
genom
posit
polar
murin
coronaviru
mhvdvim
enteropathogen
coronaviru
caus
sever
diarrhea
newborn
mice
describ
previou
report
treatment
dvim
nonion
deterg
isol
protein
carri
function
site
acetylesteras
ae
haemagglutin
ha
activ
contribut
activ
infect
mhvdvim
yet
known
relat
antigen
epitop
know
antigen
properti
sever
monoclon
antibodi
mab
rais
purifi
protein
establish
use
character
protein
present
report
provid
evid
function
site
ae
ha
activ
separ
locat
protein
furthermor
mab
inhibit
ae
activ
also
suppress
abil
dvim
caus
cell
fusion
within
murin
coronaviru
mhvdvim
grown
dbt
cell
use
eagl
mem
supplement
newborn
calf
serum
gibco
tryptos
phosphat
broth
difco
viru
purifi
describ
previous
ae
activ
determin
accord
method
describ
vlasak
et
al
purifi
virion
dissolv
l
pb
l
gl
react
l
mab
gl
dilut
rate
h
room
temperatur
addit
l
esteras
substrat
l
mm
pnitrophenilacet
dissolv
acetonitril
solut
incub
min
c
hydrolysi
substrat
monitor
od
spectrophotomet
hitachi
inhibitori
effect
express
percentag
blank
contain
pb
instead
viru
ha
assay
perform
vshape
microtit
plate
describ
previous
use
volvol
erythrocyt
balbc
mice
dulbecco
pb
ph
supplement
bovin
serum
albumin
bsa
sigma
titer
record
reciproc
valu
highest
dilut
caus
detect
ha
reaction
hai
assay
also
carri
microtit
plate
aliquot
l
purifi
virion
react
l
serial
twofold
dilut
mab
v
plate
h
c
l
vv
erythrocyt
ad
incub
h
c
hi
titer
record
reciproc
valu
highest
dilut
caus
detect
inhibitori
effect
prepar
method
describ
previou
paper
neutral
test
mab
carri
semimicro
reduct
assay
viru
tcid
ml
mix
dilut
antibodi
incub
h
c
plate
onto
plate
adsorpt
h
room
temperatur
plate
wash
pb
ph
cultur
medium
ad
cell
neutral
titer
express
highest
antibodi
dilut
prevent
viru
infect
tcid
ml
ratio
fusion
format
calcul
number
nuclei
cell
form
syncytium
sinc
identifi
glycoprotein
dvim
attempt
character
antigen
site
glycoprotein
obtain
seven
clone
lgg
hai
determin
describ
materi
method
b
aei
determin
dilut
mab
c
neutral
activ
express
reciproc
highest
dilut
mab
show
fusogen
cpe
h
post
infect
cpe
syncytium
develop
overal
cell
sheet
fig
reactiv
mab
protein
dvim
shown
western
blot
analysi
solubil
sampl
buffer
dvim
virion
subject
electrophoresi
sdspolyacrylamid
gel
follow
transfer
nitrocellulos
membran
protein
incub
mab
describ
materi
method
neg
control
pb
react
instead
antibodi
molecular
weight
indic
left
arrow
right
side
point
protein
dvim
mab
direct
glycoprotein
identifi
belong
igg
isotyp
tabl
react
polypeptid
kda
dvim
western
blot
analysi
indic
recogn
epitop
exist
glycoprotein
fig
mab
also
examin
crossreact
strain
mhv
well
influenza
c
viru
also
contain
acetylesteras
western
blot
analysi
shown
fig
six
mab
recogn
major
kda
protein
mhvjhm
crossreact
observ
influenza
viru
fig
howev
mab
also
react
mhv
result
indic
glycoprotein
dvim
antigen
similar
mhvjhm
extent
also
mhv
determin
biolog
properti
mab
examin
inhibitori
activ
acetylesteras
hemagglutin
fusion
within
activit
respect
inhibit
acetylesteras
aei
analyz
determin
effect
mab
abil
viral
enzym
releas
pnitrophenol
pnitrophenylacet
shown
tabl
five
mab
show
high
aei
titer
two
mab
found
low
level
aei
titer
high
hemagglutin
inhibit
hai
titer
measur
three
mab
two
mab
intermedi
valu
obtain
mab
low
hai
titer
tabl
data
suggest
mab
classifi
least
two
group
group
high
titer
activ
intermedi
titer
ha
activ
group
b
low
titer
activ
fig
tabl
determin
correl
ae
ha
activ
site
inhibitori
effect
ha
ae
activ
dfp
also
test
inhibitori
effect
shown
ae
activ
ha
activ
data
shown
result
suggest
ha
ae
activ
site
exist
glycoprotein
dvim
separ
etiolog
examin
cytopath
effect
mab
respect
format
syncytia
dviminfect
cell
fusion
evid
h
postinfect
pi
mab
unabl
prevent
cytopath
effect
syncytia
format
observ
h
pi
viru
treat
mab
prior
infect
fig
note
howev
antibodi
complet
neutral
dvim
delay
control
v
viru
control
b
c
e
f
cytopath
effect
fusion
within
shown
asterik
viru
cell
fusion
activ
syncytia
observ
h
pi
fig
data
indic
exist
neutral
factor
glycoprotein
dvim
role
protein
viru
infect
unclear
virus
bovin
coronaviru
human
coronaviru
protein
appear
essenti
variant
mutant
lack
protein
found
esteras
activ
suggest
play
role
either
viru
entri
viru
releas
though
mhv
serolog
relat
differ
virus
serogroup
sever
aspect
bovin
human
counterpart
use
sialic
acid
plasma
membran
bind
cell
biliari
glycoprotein
serv
receptor
mhv
addit
strain
mhv
contain
heprotein
other
lack
protein
even
strain
like
dvim
contain
heprotein
thu
abl
releas
oacetyl
group
acid
use
biliari
glycoprotein
receptor
thu
import
heprotein
mhv
known
obtain
inform
protein
rais
antibodi
protein
analyz
effect
biolog
activ
respect
inhibit
hemagglutin
activ
acetylesteras
activ
antibodi
high
titer
activ
high
titer
one
activ
intermedi
titer
activ
two
antibodi
low
titer
activ
result
conclud
sever
epitop
present
protein
data
also
indic
function
site
hemagglutin
acetylesteras
activ
similar
ident
none
antibodi
complet
neutral
dvim
howev
antibodi
delay
onset
syncytium
format
cytopath
affect
antibodi
high
aei
activ
high
intermedi
hai
activ
antibodi
low
titer
activ
delay
fusion
infect
cell
therefor
function
acetylesteras
activ
andor
hemagglutin
activ
appear
necessari
optim
infect
dvim
investig
need
determin
exact
role
protein
antibodi
describ
help
respect
